Guest
Guest
Aug 24, 2026
7:44 PM
|
Human erythropoietin (hEPO) is an essential survival and growth factor and plays an essential role in the production and maturation of red blood cells. Therefore, the hEPO is a common choice for treatment of the anemia. With the application of recombinant DNA technology, the hEPO gene has been molecularly cloned, sequenced, and expressed in a biologically active form in mammalian cells. The recombinant hEPO products have been used in the treatment of anemia caused by renal causes and malignant tumor radiotherapy and chemotherapy.
|
